Published in Am J Drug Alcohol Abuse on January 01, 2010
Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review. J Subst Abuse Treat (2014) 0.86
A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine. Nicotine Tob Res (2013) 0.85
Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan. Subst Abuse Treat Prev Policy (2012) 0.79
Prevalence of depression during pregnancy: systematic review. Obstet Gynecol (2004) 5.42
A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med (2008) 4.57
Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry (2009) 3.94
Smoking cessation in methadone maintenance. Addiction (2002) 2.62
Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy. Am J Obstet Gynecol (2009) 2.30
Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf (2005) 2.21
Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women. Health Psychol (2000) 2.17
If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents? Neurotoxicol Teratol (2008) 2.04
Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2009) 2.04
The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry (2009) 2.01
Prevalence and predictors of antidepressant use in a cohort of pregnant women. BJOG (2007) 1.85
Spontaneous quitting: self-initiated smoking cessation in early pregnancy. Nicotine Tob Res (2004) 1.81
ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol (2008) 1.81
Sex and depression in the National Comorbidity Survey. II: Cohort effects. J Affect Disord (1994) 1.78
The effects of drug abuse on pregnancy. Curr Opin Obstet Gynecol (2007) 1.54
Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol (2005) 1.29
Bupropion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf (2007) 1.23
Motivational enhancement therapy for nicotine dependence in methadone-maintained pregnant women. Psychol Addict Behav (2004) 1.08
The impact of managed care on drug-dependent pregnant and postpartum women and their children. Subst Use Misuse (2007) 1.07
Depression in pregnant women seeking smoking cessation treatment. Addict Behav (2005) 1.02
Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry (2009) 1.01
Effectiveness of bupropion for smoking cessation during pregnancy. J Addict Dis (2005) 0.98
Smoking cessation medication use among pregnant and postpartum smokers. Obstet Gynecol (2008) 0.97
Diagnosis and treatment of depression during pregnancy. CNS Spectr (2004) 0.96
Use of psychotropic drugs during pregnancy. A report of the international co-operative drug use in pregnancy (DUP) study. Collaborative Group on Drug Use in Pregnancy (CGDUP). Eur J Clin Pharmacol (1993) 0.95
Smoking cessation in pregnancy: why, how, and what next... Clin Obstet Gynecol (2008) 0.94
Psychopharmacologic management of opioid-dependent women during pregnancy. Am J Addict (2009) 0.92
Bupropion. Drugs Today (Barc) (2006) 0.90
Safety of newer antidepressants in pregnancy. Pharmacotherapy (2007) 0.89
The fetus and maternal depression: implications for antenatal treatment guidelines. Clin Obstet Gynecol (2004) 0.82
Categorizing the safety of medications during pregnancy and lactation. J Psychosoc Nurs Ment Health Serv (2009) 0.82
Caffeinated energy drinks--a growing problem. Drug Alcohol Depend (2008) 4.98
Buprenorphine: how to use it right. Drug Alcohol Depend (2003) 2.35
Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict (2008) 2.17
Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain (2013) 1.89
Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument. Drug Alcohol Depend (2009) 1.56
A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence. J Addict Med (2013) 1.47
Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus? J Matern Fetal Neonatal Med (2012) 1.43
Prescriptions, nonmedical use, and emergency department visits involving prescription stimulants. J Clin Psychiatry (2016) 1.39
Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend (2003) 1.36
Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone. Drug Alcohol Depend (2007) 1.28
Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend (2004) 1.26
Characteristics of older opioid maintenance patients. J Subst Abuse Treat (2005) 1.22
Mood disorders affect drug treatment success of drug-dependent pregnant women. J Subst Abuse Treat (2006) 1.22
Reinforcement-based therapy: 12-month evaluation of an outpatient drug-free treatment for heroin abusers. Drug Alcohol Depend (2005) 1.21
Decreased frontal white-matter volume in chronic substance abuse. Int J Neuropsychopharmacol (2005) 1.20
HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone. J Subst Abuse Treat (2006) 1.17
A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes. Subst Abuse (2013) 1.16
Changing profile of abused substances by older persons entering treatment. J Nerv Ment Dis (2008) 1.16
Response to Wouldes and Woodward: maternal methadone dose during pregnancy and infant clinical outcome. Neurotoxicol Teratol (2013) 1.15
Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence. Exp Clin Psychopharmacol (2005) 1.14
The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review. Drug Alcohol Depend (2011) 1.14
Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry (2007) 1.14
Reinforcement-based treatment improves the maternal treatment and neonatal outcomes of pregnant patients enrolled in comprehensive care treatment. Am J Addict (2011) 1.13
Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data. Am J Addict (2013) 1.10
A partner's drug-using status impacts women's drug treatment outcome. Drug Alcohol Depend (2003) 1.08
Outpatient treatment entry and health care utilization after a combined medical/substance abuse intervention for hospitalized medical patients. J Gen Intern Med (2002) 1.08
The impact of managed care on drug-dependent pregnant and postpartum women and their children. Subst Use Misuse (2007) 1.07
Modest opioid withdrawal suppression efficacy of oral tramadol in humans. Psychopharmacology (Berl) (2007) 1.06
A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients. Alcohol Clin Exp Res (2012) 1.05
Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: behavioral treatment + naltrexone compared to usual care. Drug Alcohol Depend (2011) 1.02
Treating the partners of opioid-dependent pregnant patients: feasibility and efficacy. Am J Drug Alcohol Abuse (2011) 1.00
Comparing homeless and domiciled pregnant substance dependent women on psychosocial characteristics and treatment outcomes. Drug Alcohol Depend (2003) 0.98
Cigarette smoking knowledge, attitudes, and practices of patients and staff at a perinatal substance abuse treatment center. J Subst Abuse Treat (2010) 0.98
Service use and barriers to mental health care among adults with major depression and comorbid substance dependence. Psychiatr Serv (2013) 0.97
Double jeopardy--drug and sex risks among Russian women who inject drugs: initial feasibility and efficacy results of a small randomized controlled trial. Subst Abuse Treat Prev Policy (2012) 0.97
Voucher-based reinforcement of opiate abstinence during methadone detoxification. Drug Alcohol Depend (2002) 0.97
Lessons learned from a randomized trial of fixed and escalating contingency management schedules in opioid-dependent pregnant women. Am J Drug Alcohol Abuse (2012) 0.97
Discriminative stimulus effects of tramadol in humans. J Pharmacol Exp Ther (2011) 0.97
Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. Addiction (2012) 0.96
Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period. Psychopharmacology (Berl) (2006) 0.95
Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am J Addict (2010) 0.95
Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes. Drug Alcohol Depend (2012) 0.95
Fetal neurobehavioral effects of exposure to methadone or buprenorphine. Neurotoxicol Teratol (2010) 0.94
Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans. Addiction (2003) 0.94
Twice stigmatized: provider's perspectives on drug-using women in the Republic of Georgia. J Psychoactive Drugs (2013) 0.94
The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients. Am J Drug Alcohol Abuse (2009) 0.93
Treatment of patients with substance use disorders, second edition. American Psychiatic Association. Am J Psychiatry (2006) 0.93
Suicidality, aggression, and other treatment considerations among pregnant, substance-dependent women with posttraumatic stress disorder. Compr Psychiatry (2009) 0.92
Psychopharmacologic management of opioid-dependent women during pregnancy. Am J Addict (2009) 0.92
What if they do not want treatment?: lessons learned from intervention studies of non-treatment-seeking, drug-using pregnant women. Am J Addict (2004) 0.92
Determination of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, 2-ethyl-5-methyl-3,3-diphenylpyraline and methadol in meconium by liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.92
Impact of formulation on the abuse liability, safety and regulation of medications: the expert panel report. Drug Alcohol Depend (2006) 0.91
Partner violence impacts the psychosocial and psychiatric status of pregnant, drug-dependent women. Addict Behav (2004) 0.91
Relationship between cigarette use and mood/anxiety disorders among pregnant methadone-maintained patients. Am J Addict (2009) 0.91
Physical dependence potential of daily tramadol dosing in humans. Psychopharmacology (Berl) (2010) 0.90
Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol. J Opioid Manag (2012) 0.90
A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients. J Subst Abuse Treat (2011) 0.89
Neonatal neurobehavior effects following buprenorphine versus methadone exposure. Addiction (2012) 0.88
Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans. Exp Clin Psychopharmacol (2006) 0.87
Behavioral treatment + naltrexone reduces drug use and legal problems in the Republic of Georgia. Am J Drug Alcohol Abuse (2012) 0.87
Fetal assessment before and after dosing with buprenorphine or methadone. Addiction (2012) 0.87
Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers. Drug Alcohol Depend (2010) 0.87
Suicidal Ideation Among Drug-Dependent Treatment-Seeking Inner-City Pregnant Women. J Maint Addict (2008) 0.86
A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine. Nicotine Tob Res (2013) 0.85
Post-cesarean pain management of patients maintained on methadone or buprenorphine. Am J Addict (2006) 0.85
Maternal treatment with opioid analgesics and risk for birth defects: additional considerations. Am J Obstet Gynecol (2011) 0.85
Dosing adjustments in postpartum patients maintained on buprenorphine or methadone. J Addict Med (2008) 0.85
Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration. Clin Chem (2007) 0.85
A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers. Drug Alcohol Depend (2004) 0.85
Employment-based abstinence reinforcement promotes opiate and cocaine abstinence in out-of-treatment injection drug users. J Appl Behav Anal (2014) 0.84
Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers. Psychopharmacology (Berl) (2010) 0.84
Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone. Psychopharmacology (Berl) (2010) 0.83
Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.83
Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient. Am J Psychiatry (2007) 0.83
Comparison of demographic and clinical characteristics between opioid-dependent individuals admitted to a community-based treatment setting and those enrolled in a research-based treatment setting. J Subst Abuse Treat (2007) 0.83
Increased blood pressure after abrupt cessation of daily cannabis use. J Addict Med (2011) 0.82
Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates. Addiction (2012) 0.82
An fMRI investigation of cerebellar function during verbal working memory in methadone maintenance patients. Cerebellum (2012) 0.82
A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine. J Pharmacol Exp Ther (2013) 0.81
Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication. Addiction (2012) 0.81
Abstinence-contingent recovery housing and reinforcement-based treatment following opioid detoxification. Addiction (2012) 0.81
Methadone and metabolites in hair of methadone-assisted pregnant women and their infants. Ther Drug Monit (2012) 0.80
Usefulness of salivary trans-3'-hydroxycotinine concentration and trans-3'-hydroxycotinine/cotinine ratio as biomarkers of cigarette smoke in pregnant women. J Anal Toxicol (2005) 0.80
Pretreatment alcohol drinking goals are associated with treatment outcomes. Alcohol Clin Exp Res (2013) 0.80
Gender differences in substance abuse treatment and barriers to care among persons with substance use disorders with and without comorbid major depression. J Addict Med (2013) 0.79
The efficacy of escalating and fixed contingency management reinforcement on illicit drug use in opioid-dependent pregnant women. Addict Disord Their Treat (2012) 0.79
Safety and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine dependence: a randomized clinical trial. Am J Addict (2005) 0.78
Female partners of opioid-injecting men in the Republic of Georgia: an initial characterization. Subst Abuse Treat Prev Policy (2012) 0.78
Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes. Addiction (2012) 0.78
Excretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administration. Ther Drug Monit (2010) 0.78